Delivery Order SPE8EQ24D0005-SPE8EQ25F0035

Award Date 12/29/24
Potential Completion Date 1/29/25
Potential Value $6K
Federal Agency
Pacific Region
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Japan
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Pacific to Alfresa Corporation, a Japan-based medical device and life sciences company. The $144,543.06 firm-fixed price contract is for the delivery of medical reagents, laboratory equipment, and diagnostic supplies to various U.S. military facilities in Japan, including Naval Hospital Yokosuka, Iwakuni, Sasebo, and Atsugi, as well as the Diego Garcia military base. Alfresa Corporation holds multiple Indefinite...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Pacific to Alfresa Corporation, a Japan-based medical device and life sciences company. The contract, valued at $963,140.20, is for the delivery of medical reagents, laboratory equipment, diagnostic supplies, and preventive maintenance services to U.S. military facilities in the Pacific region, including Naval Hospital Yokosuka, Iwakuni, Sasebo, and Atsugi, as well as Diego Garcia. This...
This is a federal delivery order award made by the Defense Logistics Agency (DLA) Pacific Region to Alfresa Corporation, a Japan-based medical device and life sciences company. The $302,502.06 firm-fixed price contract is for the delivery of medical reagents, laboratory equipment, diagnostic supplies, and preventive maintenance services to U.S. military facilities in the Pacific region, including naval bases in Japan. The contract has an ultimate completion date of June 30, 2016 and was...
This federal contract award, with ID SPE8EQ24D0004|SPE8EQ25F0033, was issued by the Defense Logistics Agency (DLA) Troop Support Pacific to Alfresa Corporation, a Japan-based medical device and life sciences company. The $11,957.14 firm-fixed-price delivery order contract is for the provision of reagents to the Naval Medical Research Center (NMRTC) Yokosuka. The contract has an ultimate completion date of January 29, 2025. Alfresa Corporation holds multiple Indefinite Delivery Contracts (IDCs)...
The U.S. Defense Logistics Agency (DLA) Troop Support Pacific awarded a Firm Fixed Price Delivery Order contract to Alfresa Corporation, a Japanese medical device and life sciences company, for the supply of laboratory reagents, diagnostic equipment, and consumable supplies to support U.S. military operations and medical treatment facilities in the Pacific region. The contract, with a ceiling value of $10,820.14, has an ultimate completion date of October 19, 2022. Alfresa Corporation is an...
The Defense Logistics Agency Troop Support Pacific awarded a firm fixed price delivery order valued at five thousand thirty-four dollars and twenty-five cents ($5,034.25) to Alfresa Corporation of Japan. The order is for the delivery of Alfresa Reagents to support operations at the Yokosuka base and has an anticipated completion date of July 12, 2022. No set-aside provisions were applied to this award placed under an unspecified indefinite-delivery/indefinite-quantity contract vehicle. Alfresa...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Pacific to Alfresa Corporation, a Japan-based medical device and life sciences company. The contract, valued at $12,531.19, is a delivery order for the provision of various medical reagents, laboratory consumables, and equipment to support U.S. military operations and medical treatment facilities in the Pacific region. Alfresa Corporation has several indefinite delivery contracts (IDVs) with the DLA Troop...
This federal contract award, with ID SPE8EQ24D0004|SPE8EQ24F0141, was issued by the Defense Logistics Agency (DLA) Troop Support Pacific to Alfresa Corporation, a Japan-based medical device and life sciences company. The $4,531.90 firm-fixed price delivery order contract provides laboratory reagents, diagnostic equipment, and medical supplies to support U.S. military operations and medical treatment facilities in the Pacific region. Alfresa Corporation holds several indefinite delivery contracts...
The Defense Logistics Agency Troop Support Pacific awarded a firm fixed price delivery order valued at five thousand one hundred four dollars and seventy-one cents ($5,104.71) to Alfresa Corporation for reagents to be used at United States Naval Hospital Yokosuka in Japan. The contract has a completion date of March 30, 2023 and was awarded on March 22, 2023. No set-aside designation was applied to this award. Alfresa Corporation will serve as the prime contractor to supply the requested...
<p>The Defense Logistics Agency Troop Support Pacific awarded a $5,231.09 firm fixed price delivery order to Alfresa Corporation of Japan for ALFRESA REAGENTS - YOKOSUKA. The contract has a completion date of May 31, 2022 and was awarded on May 25, 2022. No set-aside designation was used for this award to the prime contractor Alfresa Corporation. The place of performance is Japan, where the Defense Logistics Agency supports logistics operations for U.S. forces stationed in the region.</p>
  • SPE8EQ24D0005
    Indefinite Delivery Contract
  • SPE8EQ24D0005-SPE8EQ25F0035
    Delivery Order

This federal contract award, valued at $6,024.85, was issued by the Defense Logistics Agency (DLA) Troop Support Pacific to Alfresa Corporation, a Japan-based medical device and life sciences company. The contract is a delivery order under an Indefinite Delivery Contract (IDC) and has a firm-fixed price pricing type. It is for the delivery of reagents and other medical supplies to multiple U.S. military facilities in Japan, such as Naval Hospital Yokosuka, Iwakuni, Sasebo, and Atsugi, as well as Diego Garcia. The contract has an ultimate completion date of January 29, 2025. Alfresa Corporation is a critical supplier of medical and laboratory products to the U.S. Department of Defense in the Pacific region, providing a wide range of items including diagnostic equipment, medical consumables, and specialized maintenance services. The contract was awarded without any set-aside designations, indicating Alfresa's ability to compete effectively in open market procurements.

Generated 4/13/25, 9:53 AM